{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:07:12Z","timestamp":1773248832765,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32260214"],"award-info":[{"award-number":["32260214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92477-9","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:46:32Z","timestamp":1741880792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between aldosterone and lipid profiles in patients with primary aldosteronism"],"prefix":"10.1038","volume":"15","author":[{"given":"Ning-Peng","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Rui","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Yi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Qun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"92477_CR1","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano, A. L. et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 37, 2999\u20133058. https:\/\/doi.org\/10.1093\/eurheartj\/ehw272 (2016).","journal-title":"Eur. Heart J."},{"key":"92477_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.numecd.2013.09.009","volume":"24","author":"F Turchi","year":"2014","unstructured":"Turchi, F. et al. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. Nutr. Metab. Cardiovasc. Dis. 24, 476\u2013482. https:\/\/doi.org\/10.1016\/j.numecd.2013.09.009 (2014).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"92477_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez, P. et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45, 1243\u20131248. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.015 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92477_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone, S. et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41\u201350. https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"92477_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard, S., Amar, L., Plouin, P. F. & Steichen, O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62, 331\u2013336. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01060 (2013).","journal-title":"Hypertension"},{"key":"92477_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke, M. et al. Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension 60, 618\u2013624. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.197111 (2012).","journal-title":"Hypertension"},{"key":"92477_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"Hanslik, G. et al. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur. J. Endocrinol. 173, 665\u2013675. https:\/\/doi.org\/10.1530\/EJE-15-0450 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"92477_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cen.13891","volume":"90","author":"A Berends","year":"2019","unstructured":"Berends, A. et al. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. Clin. Endocrinol. 90, 79\u201387. https:\/\/doi.org\/10.1111\/cen.13891 (2019).","journal-title":"Clin. Endocrinol."},{"key":"92477_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","volume":"20","author":"F Fallo","year":"2007","unstructured":"Fallo, F. et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am. J. Hypertens. 20, 855\u2013861. https:\/\/doi.org\/10.1016\/j.amjhyper.2007.03.012 (2007).","journal-title":"Am. J. Hypertens."},{"key":"92477_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","volume":"53","author":"J Matrozova","year":"2009","unstructured":"Matrozova, J. et al. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53, 605\u2013610. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.122002 (2009).","journal-title":"Hypertension"},{"key":"92477_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone, S. et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69, 1811\u20131820. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.052 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92477_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3803\/EnM.2021.1012","volume":"36","author":"SJ Moon","year":"2021","unstructured":"Moon, S. J., Jang, H. N., Kim, J. H. & Moon, M. K. Lipid profiles in primary aldosteronism compared with essential hypertension: Propensity-score matching study. Endocrinol. Metab. 36, 885\u2013894. https:\/\/doi.org\/10.3803\/EnM.2021.1012 (2021).","journal-title":"Endocrinol. Metab."},{"key":"92477_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916. https:\/\/doi.org\/10.1210\/jc.2015-4061 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"92477_CR14","unstructured":"Chinese Guidelines for the Prevention and Treatment of Hypertension (2018). The Chinese Cardiovascular Journal. 24:24\u201356. (2019).(in Chinese)"},{"key":"92477_CR15","first-page":"937","volume":"31","author":"Z Junxian","year":"2016","unstructured":"Junxian, Z., Runlin, G., Zhao Shuiping, Lu., Guoping, Z. D. & Jianjun, Li. Guidelines for the prevention and treatment of dyslipidemia in China (2016). China Circ. Mag. 31, 937\u2013953 (2016).","journal-title":"China Circ. Mag."},{"key":"92477_CR16","doi-asserted-by":"publisher","first-page":"4128174","DOI":"10.1155\/2018\/4128174","volume":"2018","author":"M Hannich","year":"2018","unstructured":"Hannich, M. et al. Physiological aldosterone concentrations are associated with alterations of lipid metabolism: Observations from the general population. Int. J. Endocrinol. 2018, 4128174. https:\/\/doi.org\/10.1155\/2018\/4128174 (2018).","journal-title":"Int. J. Endocrinol."},{"key":"92477_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/EJE-10-1074","volume":"164","author":"A Hannemann","year":"2011","unstructured":"Hannemann, A. et al. Association of plasma aldosterone with the metabolic syndrome in two German populations. Eur. J. Endocrinol. 164, 751\u2013758. https:\/\/doi.org\/10.1530\/EJE-10-1074 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"92477_CR18","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.2337\/dc12-2562","volume":"36","author":"SK Musani","year":"2013","unstructured":"Musani, S. K. et al. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study. Diabetes Care 36, 3084\u20133092. https:\/\/doi.org\/10.2337\/dc12-2562 (2013).","journal-title":"Diabetes Care"},{"issue":"5","key":"92477_CR19","first-page":"836","volume":"834","author":"Z Beibei","year":"2019","unstructured":"Beibei, Z. et al. Characteristics of the abdominal fat distribution profile in patients with primary hyperaldosteronism. Chin. J. Endocrinol. Metab. 834(5), 836\u2013837 (2019).","journal-title":"Chin. J. Endocrinol. Metab."},{"issue":"2","key":"92477_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/ijms26020540","volume":"26","author":"N Ekman","year":"2025","unstructured":"Ekman, N. et al. Non-hypertensive effects of aldosterone. Int. J. Mol. Sci. 26(2), 540. https:\/\/doi.org\/10.3390\/ijms26020540 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"92477_CR21","doi-asserted-by":"publisher","first-page":"00323","DOI":"10.1016\/j.tem.2024.12.001","volume":"S1043\u20132760","author":"H Wu","year":"2025","unstructured":"Wu, H., He, H., Han, T., Tian, X. & Zhu, Z. Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism. Trends Endocrinol. Metab. S1043\u20132760(24), 00323. https:\/\/doi.org\/10.1016\/j.tem.2024.12.001 (2025).","journal-title":"Trends Endocrinol. Metab."},{"key":"92477_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mam.2016.04.001","volume":"49","author":"S Maqdasy","year":"2016","unstructured":"Maqdasy, S. et al. Once and for all, LXR\u03b1 and LXR\u03b2 are gatekeepers of the endocrine system. Mol. Aspects Med. 49, 31\u201346. https:\/\/doi.org\/10.1016\/j.mam.2016.04.001 (2016).","journal-title":"Mol. Aspects Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92477-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:46:38Z","timestamp":1741880798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92477"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92477-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the Second Affiliated Hospital of Nanchang University and was part of the study of the Nanchang Primary Aldosteronism Study (IIT-O-2021-032). It was registered on chictr.org (ChiCTR2200057297). Signed informed consent was obtained from each patient before participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"8755"}}